1. Charles Fettinger Charles Fettinger United States says:

    Not only is antibody response not correlated to positive outcomes for many groups of Covid-19 patients, the durability of antibodies is the weaker as age and other correlated factors increase.

    Then there the issue of variants using older variant antibodies to escape immune response.  

    I am very skeptical of this suggestion from this article and am concerned that it is just a push to lower inventory of the mRNA treatment.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment